These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16198664)

  • 21. In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease.
    Ohnishi A; Murakami S; Akizuki S; Mochizuki J; Echizen H; Takagi I
    J Clin Pharmacol; 2005 Nov; 45(11):1221-9. PubMed ID: 16239354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW; Goh KL; Wong BC
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
    Niioka T; Uno T; Sugimoto K; Sugawara K; Hayakari M; Tateishi T
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1031-8. PubMed ID: 17701405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
    Clin Pharmacol Ther; 2006 Nov; 80(5):539-48. PubMed ID: 17112810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.
    de Leon J
    J Clin Psychopharmacol; 2007 Jun; 27(3):241-5. PubMed ID: 17502769
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment.
    Rost KL; Brockmöller J; Esdorn F; Roots I
    J Hepatol; 1995 Sep; 23(3):268-77. PubMed ID: 8550990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.
    Kim KA; Shon JH; Park JY; Yoon YR; Kim MJ; Yun DH; Kim MK; Cha IJ; Hyun MH; Shin JG
    Clin Pharmacol Ther; 2002 Jul; 72(1):90-9. PubMed ID: 12152007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent anaphylaxis linked to pantoprazole.
    Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
    J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug metabolism and variability among patients in drug response.
    Wilkinson GR
    N Engl J Med; 2005 May; 352(21):2211-21. PubMed ID: 15917386
    [No Abstract]   [Full Text] [Related]  

  • 31. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study.
    Balian JD; Sukhova N; Harris JW; Hewett J; Pickle L; Goldstein JA; Woosley RL; Flockhart DA
    Clin Pharmacol Ther; 1995 Jun; 57(6):662-9. PubMed ID: 7781266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
    Rengelshausen J; Banfield M; Riedel KD; Burhenne J; Weiss J; Thomsen T; Walter-Sack I; Haefeli WE; Mikus G
    Clin Pharmacol Ther; 2005 Jul; 78(1):25-33. PubMed ID: 16003289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort.
    Bolley R; Zülke C; Kammerl M; Fischereder M; Krämer BK
    Transplantation; 2002 Mar; 73(6):1009. PubMed ID: 11923712
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
    Ohkusa T; Maekawa T; Arakawa T; Nakajima M; Fujimoto K; Hoshino E; Mitachi Y; Hamada S; Mine T; Kawahara Y; Nagai T; Aoyama N; Yoshida N; Tadokoro K; Chida N; Konda Y; Seno H; Shimatani T; Inoue M; Sato N
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1331-9. PubMed ID: 15932363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. St. John's Wort: more implications for cancer patients.
    Mansky PJ; Straus SE
    J Natl Cancer Inst; 2002 Aug; 94(16):1187-8. PubMed ID: 12189216
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective metabolism by human liver CYP enzymes of a substituted benzimidazole.
    Abelö A; Andersson TB; Bredberg U; Skånberg I; Weidolf L
    Drug Metab Dispos; 2000 Jan; 28(1):58-64. PubMed ID: 10611141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic versus brand-name medicinal products: are they really interchangeable?
    Motola D; De Ponti F
    Dig Liver Dis; 2006 Aug; 38(8):560-2. PubMed ID: 16731062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.